When Bruce Masales was diagnosed with Stage 4 bladder cancer, he says the news came without warning.But as a longtime ...
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...
Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...
The findings in a small study is ‘significant enough to warrant urgent further investigation’, researchers said.
A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results